Form 4 holding
Director
Amneal Pharmaceuticals, Inc.
- Security class
- Class A Common Stock
- Shares / value
- 832,800
- Estimated value
- $10,351,704
- Report date
- 07 May 2026
- Price
- $12.43
- Ownership
- Direct
Paul M. Meister
Insider Reports History
- Reporting-owner location
- Troy, MI
- Latest reporting-owner signature
-
/s/ Rachel V. Friedenberg, Attorney-in-fact for Paul M. Meister
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Paul M. Meister
Form 4 holding
Director
Aptiv PLC
- Security class
- Ordinary Shares
- Shares / value
- 105,631
- Estimated value
- $4,999,958
- Report date
- 05 Aug 2026
- Price
- $47.33
- Ownership
- Woburn Abbey March 2021 Trust GST Exempt Share
Form 4 holding
Director
Quanterix Corp
- Security class
- Common Stock
- Shares / value
- 313,253
- Estimated value
- $1,992,414
- Report date
- 02 Jan 2026
- Price
- $6.36
- Ownership
- Direct
Form 4 holding
Director
Aptiv PLC
- Security class
- Ordinary Shares
- Shares / value
- 19,181
- Estimated value
- $1,177,329
- Report date
- 05 Aug 2026
- Price
- $61.38
- Ownership
- Paul M. Meister 2005 Revocable Trust
Form 4 holding
Director
Aptiv PLC
- Security class
- Ordinary Shares
- Shares / value
- 13,612
- Estimated value
- $835,504
- Report date
- 05 Aug 2026
- Price
- $61.38
- Ownership
- Direct
Form 4 holding
Director, 10%+ Owner
Telesis Bio Inc.
- Security class
- Common Stock
- Shares / value
- 108,270
- Estimated value
- $305,982
- Report date
- 06 Jun 2023
- Price
- $2.83
- Ownership
- Direct
Form 4 holding
Director
Amneal Pharmaceuticals, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 30,837
- Estimated value
- $0
- Report date
- 06 May 2026
- Price
- $5.31
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Telesis Bio Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 162,406
- Estimated value
- Report date
- 06 Jun 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Versigent PLC
- Security class
- Ordinary Shares
- Shares / value
- 11,561
- Estimated value
- Report date
- 22 Apr 2026
- Price
- Ownership
- Direct
Insider Reports Filed by Paul M. Meister
4
APTV
Aptiv PLC
- Report period
- 05 Aug 2026
- Transactions
- 1
- Transaction value
- +$4,999,959
- Accepted by SEC
- 06 Aug 2026, 16:05
- Role
- Director
- Next action
- Open filing details
4
AMRX
Amneal Pharmaceuticals, Inc.
- Report period
- 06 May 2026
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 08 May 2026, 16:22
- Role
- Director
- Next action
- Open filing details
4
APTV
Aptiv PLC
- Report period
- 28 Apr 2026
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 30 Apr 2026, 16:04
- Role
- Director
- Next action
- Open filing details
4
VGNT
Versigent PLC
- Report period
- 22 Apr 2026
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 24 Apr 2026, 16:06
- Role
- Director
- Next action
- Open filing details
3
VGNT
Versigent PLC
- Report period
- 01 Apr 2026
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 06 Apr 2026, 20:58
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 02 Jan 2026
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 15 Jan 2026, 13:56
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 01 Jul 2025
- Transactions
- 1
- Transaction value
- +$14,999
- Accepted by SEC
- 02 Jul 2025, 17:39
- Role
- Director
- Next action
- Open filing details
4
APTV
Aptiv PLC
- Report period
- 14 May 2025
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 15 May 2025, 16:04
- Role
- Director
- Next action
- Open filing details
4
AMRX
Amneal Pharmaceuticals, Inc.
- Report period
- 05 May 2025
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 08 May 2025, 18:53
- Role
- Director
- Next action
- Open filing details
4
APTV
Aptiv PLC
- Report period
- 22 Apr 2025
- Transactions
- 2
- Transaction value
- -$12,077
- Accepted by SEC
- 24 Apr 2025, 16:08
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 01 Apr 2025
- Transactions
- 1
- Transaction value
- +$16,523
- Accepted by SEC
- 03 Apr 2025, 16:14
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 02 Jan 2025
- Transactions
- 3
- Transaction value
- +$14,999
- Accepted by SEC
- 06 Jan 2025, 17:45
- Role
- Director
- Next action
- Open filing details
3
OACC
Oaktree Acquisition Corp. III Life Sciences
- Report period
- 23 Oct 2024
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 23 Oct 2024, 20:11
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 01 Oct 2024
- Transactions
- 1
- Transaction value
- +$15,000
- Accepted by SEC
- 02 Oct 2024, 16:06
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 01 Jul 2024
- Transactions
- 1
- Transaction value
- +$14,988
- Accepted by SEC
- 02 Jul 2024, 17:41
- Role
- Director
- Next action
- Open filing details
4
AMRX
Amneal Pharmaceuticals, Inc.
- Report period
- 10 May 2024
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 14 May 2024, 16:44
- Role
- Director
- Next action
- Open filing details
4
AMRX
Amneal Pharmaceuticals, Inc.
- Report period
- 02 May 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 06 May 2024, 17:11
- Role
- Director
- Next action
- Open filing details
4
APTV
Aptiv PLC
- Report period
- 23 Apr 2024
- Transactions
- 2
- Transaction value
- -$23,674
- Accepted by SEC
- 25 Apr 2024, 16:05
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 01 Apr 2024
- Transactions
- 1
- Transaction value
- +$14,981
- Accepted by SEC
- 03 Apr 2024, 16:04
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 02 Jan 2024
- Transactions
- 3
- Transaction value
- +$14,987
- Accepted by SEC
- 04 Jan 2024, 16:09
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 02 Oct 2023
- Transactions
- 1
- Transaction value
- +$14,984
- Accepted by SEC
- 04 Oct 2023, 16:02
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 03 Jul 2023
- Transactions
- 1
- Transaction value
- +$14,990
- Accepted by SEC
- 05 Jul 2023, 16:14
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 07 Jun 2023
- Transactions
- 2
- Transaction value
- +$67,438
- Accepted by SEC
- 08 Jun 2023, 16:25
- Role
- Director
- Next action
- Open filing details
4
TBIO
Telesis Bio Inc.
- Report period
- 06 Jun 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 08 Jun 2023, 18:12
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
AMRX
Amneal Pharmaceuticals, Inc.
- Report period
- 09 May 2023
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 11 May 2023, 16:15
- Role
- Director
- Next action
- Open filing details
4
APTV
Aptiv PLC
- Report period
- 25 Apr 2023
- Transactions
- 2
- Transaction value
- -$40,314
- Accepted by SEC
- 27 Apr 2023, 16:18
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 03 Apr 2023
- Transactions
- 1
- Transaction value
- +$14,999
- Accepted by SEC
- 04 Apr 2023, 16:09
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 03 Jan 2023
- Transactions
- 3
- Transaction value
- +$14,995
- Accepted by SEC
- 04 Jan 2023, 15:03
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 03 Oct 2022
- Transactions
- 1
- Transaction value
- +$14,997
- Accepted by SEC
- 05 Oct 2022, 16:05
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 10 Aug 2022
- Transactions
- 2
- Transaction value
- +$1,998,314
- Accepted by SEC
- 10 Aug 2022, 18:22
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 01 Jul 2022
- Transactions
- 1
- Transaction value
- +$14,993
- Accepted by SEC
- 06 Jul 2022, 16:07
- Role
- Director
- Next action
- Open filing details
4
AMRX
Amneal Pharmaceuticals, Inc.
- Report period
- 08 May 2022
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 10 May 2022, 18:46
- Role
- Director
- Next action
- Open filing details
4
APTV
Aptiv PLC
- Report period
- 26 Apr 2022
- Transactions
- 2
- Transaction value
- -$19,169
- Accepted by SEC
- 28 Apr 2022, 16:22
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 01 Apr 2022
- Transactions
- 1
- Transaction value
- +$14,991
- Accepted by SEC
- 05 Apr 2022, 16:03
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 03 Jan 2022
- Transactions
- 3
- Transaction value
- +$13,741
- Accepted by SEC
- 05 Jan 2022, 15:05
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 01 Oct 2021
- Transactions
- 1
- Transaction value
- +$13,767
- Accepted by SEC
- 05 Oct 2021, 16:01
- Role
- Director
- Next action
- Open filing details
4
QTRX
Quanterix Corp
- Report period
- 01 Jul 2021
- Transactions
- 1
- Transaction value
- +$13,740
- Accepted by SEC
- 06 Jul 2021, 16:16
- Role
- Director
- Next action
- Open filing details
4
AMRX
Amneal Pharmaceuticals, Inc.
- Report period
- 05 May 2021
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 07 May 2021, 14:07
- Role
- Director
- Next action
- Open filing details